SSG
NXTM

Summit Securities Group’s NxStage Medical Inc. NXTM Stock Holding History

Summit Securities Group’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-800
Closed -$11K – 617
2013
Q2 		$11K Buy
+800
New +$10.1K 0.01% 308

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Summit Securities Group's NXTM Position: Q3 2013 in Review

Summit Securities Group sold out of NxStage Medical Inc. (NXTM) in Q3 2013, closing a stake of 800 shares — an estimated $11K sold.

Summit Securities Group first reported a position in NXTM in Q2 2013 and held it in 1 quarter. The position peaked at $11K in Q2 2013. 115 funds tracked by Wall St. Rank hold NXTM as of Q3 2013.

  • Summit Securities Group reported no remaining NxStage Medical Inc. position as of Q3 2013 after selling out during the quarter.
  • Summit Securities Group sold 800 NxStage Medical Inc. shares in Q3 2013, an estimated $11K.
  • Summit Securities Group first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 1 quarter.
  • Summit Securities Group's NxStage Medical Inc. position peaked at $11K in Q2 2013.
  • 115 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2013.

Based on Summit Securities Group's 13F filing for Q3 2013, filed 1 Nov 2013.